Gonadorelin: Uses, Evidence, Risks and Pharmacy Status

Physician-run telehealth — TN · FL · GA · OH · WA. One doctor reviews every case. No queue, no chatbot.
Medications · Men’s health

Gonadorelin: synthetic GnRH, what it does and what the evidence supports

Gonadorelin is a synthetic copy of gonadotropin-releasing hormone (GnRH), the brain signal that starts the chain leading to testosterone and sperm production. Its clearest medical use is in rare hormone disorders, given by a pump. A newer off-label use is as an add-on for men on testosterone therapy who want to protect fertility. This page explains both, and where the evidence runs thin.

Information current as of November 10, 2026. Educational only. Confirm everything here with your own clinician before starting, stopping or changing any medication.

At a glance

What it is

A 10 amino acid peptide identical to GnRH, which the hypothalamus makes. It tells the pituitary to release LH and FSH.

Established use

Pulsatile GnRH pump therapy to start puberty or fertility in people with hypogonadotropic hypogonadism, under specialist care.

Off-label use

Added to testosterone therapy to keep the testicles working. This use rests on theory and small studies, not on large trials.

Key limit

GnRH is cleared from the blood in minutes. Pulses matter. A steady level can shut the system down instead of switching it on.

Approval history

The past FDA-approved products, Factrel and Lutrepulse, are no longer marketed. Compounded gonadorelin is not FDA-approved.

Main cautions

Injection site reactions, flushing and headache. Fertility claims need a semen analysis, not a guess.

Uses

What gonadorelin is used for

Gonadorelin has one use backed by decades of specialist practice. In people whose hypothalamus does not make GnRH properly, a small pump gives pulses of it through the day. This is called pulsatile GnRH therapy. It is used for hypogonadotropic hypogonadism, including conditions that block puberty, and to induce ovulation or sperm production when pregnancy is the goal.

The use that brings most men to this page is different. A man on testosterone therapy no longer needs his own signal, so the brain turns down LH and FSH, the testicles shrink, and sperm counts fall. Doctors have tried several add-ons to keep the system awake. hCG is the one with the most human data. Clomiphene is another. Gonadorelin is a third, used off-label.

The gap you should know about

A pump that gives a pulse every 90 minutes or so is not the same as an injection a few times a week. Gonadorelin’s half-life is a few minutes. Whether intermittent injections restart the system the way a pump does in the research is not established.

How it works

How gonadorelin works

The hypothalamus releases GnRH in bursts. Each burst tells the pituitary to release LH and FSH. LH tells the testicle to make testosterone. FSH, together with local testosterone, supports sperm production. When GnRH arrives in bursts, the pituitary responds. When it arrives continuously, the pituitary stops responding. That is the same principle behind drugs that are used to lower testosterone.

Gonadorelin is given by injection or by pump, according to the prescription. This page does not give schedules or amounts. Your physician sets those, and they depend on why it is being used.

If you take testosterone and want children now or later, tell your physician first. A semen analysis before and during treatment is the only reliable way to know what is happening to sperm.

Evidence

What the studies show

The best evidence is for pulsatile pump therapy in men whose hypothalamic-pituitary system is not working. A retrospective study of 119 men with pituitary stalk interruption syndrome compared pulsatile GnRH with combined hCG and menopausal gonadotropin. Pulsatile GnRH reached sperm production sooner, at 8 months versus 15, with a hazard ratio of 1.97. The overall success rate was lower in the GnRH group, 34 percent versus 52 percent. The men were not randomized, so the comparison is imperfect.

For the testosterone fertility use, the evidence is much weaker. A 2026 narrative review of peptide strategies for testosterone-related suppression of fertility found that direct evidence of restored sperm production or fertility remains limited.

In plain terms, gonadorelin is a reasonable thing to discuss and a hard thing to judge. If fertility matters, hCG has stronger evidence and a longer record, and your physician will say so. Trials in different populations are not directly comparable, and individual results vary.

Safety

Side effects and cautions

Gonadorelin has a long record as a diagnostic and in pump therapy. Expect redness or soreness at the injection site, and occasional flushing, nausea or headache. Allergic reactions are possible with any peptide.

It is not a testosterone replacement. If you are on testosterone, monitoring does not change: testosterone and estradiol, hematocrit and PSA, as set out on the testosterone page. If you need a drug to lower estradiol, see anastrozole.

Call your physician for

  • Hives, swelling of the face or throat, or trouble breathing
  • Testicular pain or swelling
  • Breast pain or new lumps
  • Mood changes that worry you or the people close to you

Regulatory status

Where gonadorelin stands with pharmacies

Gonadorelin was FDA-approved in the past as two products, Factrel for diagnostic testing and Lutrepulse for pump therapy. Both are discontinued. Gonadorelin does not appear on the FDA’s interim lists of nominated bulk drug substances, last updated May 2026. Its use in compounding rests on its history as the active ingredient of those approved drugs, and pharmacies prepare it as a compounded drug.

Compounded gonadorelin is not FDA-approved, and the FDA does not evaluate it for safety, effectiveness or quality before it is sold. I found no currently marketed gonadorelin product, so the FDA rule about compounded copies of marketed drugs is not the limit it is for some other medicines.

Summit’s role

What Summit does with gonadorelin

Dr. Miranda prescribes gonadorelin after a physician evaluation. The prescription is prepared by an independent, state-licensed pharmacy for you as a named patient. Dr. Miranda starts with your goals. If fertility is the goal, a semen analysis and a conversation about hCG and other options come first. Summit does not dispense or sell it, and it keeps no stock in the office.

Nothing on this page promises a prescription. If gonadorelin does not fit your history, labs and goals, you will hear why. See pricing for what the program includes, including labs.

Common questions

Questions people ask

Is gonadorelin the same as hCG?

No. Gonadorelin acts at the pituitary and mimics GnRH. hCG acts at the testicle and mimics LH. They aim at the same result by different paths.

Does gonadorelin protect fertility on testosterone?

It might, but that use is off-label and the evidence is limited. A semen analysis is the only way to know. hCG has more human data.

Why does the schedule matter so much?

GnRH works in pulses. A steady exposure can switch the pituitary off. Your physician decides the pattern, and it is not something to improvise.

Is compounded gonadorelin FDA-approved?

No. The old FDA-approved products are no longer marketed, and compounded drugs are not reviewed by the FDA for safety, effectiveness or quality.

Do I still need labs?

Yes. Testosterone, estradiol, hematocrit, PSA and, if fertility matters, a semen analysis.

Sources

Where this comes from

All retrieved November 10, 2026.

  1. Pulsatile GnRH therapy and spermatogenic outcomes versus gonadotropin therapy in pituitary stalk interruption syndrome. 2024. https://pubmed.ncbi.nlm.nih.gov/38029930/
  2. Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression. 2026 narrative review. https://pubmed.ncbi.nlm.nih.gov/42666625/
  3. FDA. Bulk drug substances nominated for use in compounding under section 503A: categories list, updated May 14, 2026. https://www.fda.gov/media/94155/download
  4. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/

Confirm with your provider. This page is general education, not medical advice, and it does not diagnose or treat anything. Every medication carries risks and is not right for everyone. Medication is prescribed only after a physician evaluation determines it is appropriate for you. Individual results vary and no outcome is guaranteed. Information current as of November 10, 2026.

Next step

Tell the physician your fertility plans first

Dr. Miranda reviews your history and labs before any treatment decision, and fertility goals change the plan.